Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 124 results for "cadila healthcare"

ACC can climb to Rs 1760, Cadila Healthcare Rs 540: Prakash Gaba
Money Control

Cadila Healthcare net profit down 65.26% in Q1

Cadila Healthcare on Friday reported a 65.26 per cent fall in its consolidated net profit to Rs 138.4 crore for the quarter ended June 30, 2017 as compared to Rs 398.4 crore in the year-ago period.Its total revenue from operations stood at Rs 2,228.8 crore, ... Prokerala, 5 days ago
Father and son Transform Cadila Health to a world beater The Financial Chronicle, 6 days ago

47 images for cadila healthcare

Money Control, 3 days ago
Money Control, 4 weeks ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 1 month ago
Money Control, 2 months ago
Money Control

Pharma weekly wrap: Pharma stocks had tough week due to GST and pricing pressures in US

The news highlights in the sector include first quarter results of Sun Pharma, Aurobindo Pharma, Cipla, Cadila Healthcare among others. The US pricing pressure looks more structural than a temporary event.
 Money Control5 days ago Stocks in the news: SBI, Cadila Health, Alembic Pharma, Grasim, Jet Airways, IndusInd  Money Control1 month ago GST to prolong pain for pharma sector finds HDFC securities  Sify1 month ago After recent slide, pharma stocks extend recovery  Sify2 months ago
Money Control

Zydus settles patent case over Aptalis' drug Canasa

Zydus group firm Cadila Healthcare today said patent litigation relating to Aptalis' drug Canasa used for treatment of ulcerative colitis has been settled. As a result of the settlement, the company's "US subsidiary, Zydus Pharmaceuticals (USA) Inc, will be ...
 Business Standard3 days ago

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today

Posted by Equitymaster Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note. At the closing bell, the BSE Sensex closed higher by 322 points and the NSE Nifty finished up 107 points. The ...
 Equitymaster.com18 hours ago Indian Indices Gain Momentum; Auto Stocks Witness Buying  Equitymaster.com1 day ago Indian Indices Trade in Red; Metal Stocks Drag  Equitymaster.com1 month ago Indian Indices Trade in Red; Pharma Stocks Witness Buying  Equitymaster.com2 months ago

Global Markets Tumble as Geopolitical Tensions Escalate

Posted by Equitymaster Global financial markets ended the week lower ahead of rising tensions between the United States and North Korea. US president Donald Trump refused to back down on its threats to North Korea. Investors rushed towards safe haven assets ...
 Equitymaster.com5 days ago

Closing Bell: Sensex ends on a subdued note, Nifty holds 10,050; Tata Steel, IOC gain

LT Finance Holdings, Jaiprakash Associates, Sarda Energy, Apollo Tyres, Bhushan Steel, Wockhardt, Sintex, Eros International, Cadila Healthcare and Torrent Power rallied up to 10 percent.
 Money Control1 week ago Market Live: Sensex opens higher, Nifty eyes 10,100; Tata Steel, Tata Motors lead  Money Control1 week ago
Sify

Biocon slides on reports of US FDA observations

Shares of Biocon Ltd fall as much as 7.6 pct to 346.70 rupees - its biggest intraday pct loss since March 2. U.S. FDA issued 10 observations pointing at aseptic practices after an inspection at the drugmaker's plant in Bengaluru, media reports said citing a ...
 Sify1 week ago
Money Control

Cadila Healthcare rises 2% as Temozolomide and Nadolol drugs receive USFDA nod

Temozolomide is a chemotherapy drug used in the management of brain tumors and Nadolol is used for hypertension (high blood pressure) and angina pectoris (chest pain).
 Money Control2 weeks ago Zydus Cadila gets USFDA nod to market anti-dementia drug  Business Standard1 week ago Zydus Cadila gets USFDA nod for blood pressure drug  Money Control1 day ago Cadila Healthcare rises 3% on Mesalamine launch in US, FDA nod for Pitavastatin  Money Control4 weeks ago
[x]  
Money Control

Cadila Healthcare in pink of health after USFDA nod for drug

Cadila Healthcare rose 2.7% to Rs 546 at 14:50 IST on BSE after the company announced that it has received final approval from US drug regulator for Mesalamine Delayed-Release Tablets, 800 mg.
 Business Standard3 weeks ago Cadila Healthcare gains 3% on USFDA nod for Mesalamine that treats ulcerative colitis  Money Control3 weeks ago Cadila Healthcare gains on starting phase II trial on anemia drug  Business Standard1 month ago Cadila Healthcare gains 1% on USFDA approval for Oxybutynin tablets  Money Control1 month ago
[x]  
Money Control

Stocks in the news: Tata Motors, Cadila, Fortis, Biocon, IDFC, Satin Credit, RCF, Gati

Tata Motors | Cadila Healthcare | Tata Power | Fortis Healthcare | Biocon | SCI | IDFC | Pokarna | Satin Creditcare | Chambal Fertiliser | NFL | GSFC | GNFC | RCF | Bhushan Steel | Tata Teleservices | Reliance Communications and Gati are stocks, which are in ...
 Money Control1 month ago Stocks in the news: Aurobindo, Cadila, Bajaj Hind, Amtek Auto, Sterlite Tech, NOCIL  Money Control1 month ago Stocks in the news: RIL, Aurobindo, Tata Motors, Strides, Titan, Amtek Auto, Cadila  Money Control2 months ago Stocks in the news: SBI, Tata Motors, Cadila, Gufic Bio, Everest Organics, CARE  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less